miPEP31 inhibits the vascular smooth muscle cell proliferation via cooperation with transcription factor Trps1

Gonghao Jiang1, Xiangxiao Li1,2, Zilong Fang1

  • 1The Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Institute of Hypertension, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Insights

miPEP31 inhibits vascular smooth muscle cell proliferation and protects against hypertension-induced vascular remodeling by suppressing miR-31 expression. This peptide shows therapeutic potential for hypertensive target organs.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Hypertension Research

Background:

  • Hypertension involves vascular remodeling driven by vascular smooth muscle cell (VSMC) proliferation.
  • MicroRNA-31 (miR-31) is implicated in VSMC proliferation and hypertensive vascular remodeling.
  • The precise role and mechanism of miPEP31, derived from pri-miRNA-31, in VSMC proliferation remain largely unknown.

Purpose of the Study:

  • To investigate the role of miPEP31 in VSMC proliferation.
  • To elucidate the underlying molecular mechanisms by which miPEP31 influences vascular remodeling.
  • To assess the therapeutic potential of miPEP31 in a mouse model of hypertension.

Main Methods:

  • Administration of synthetic miPEP31 and genetic deficiency models in Angiotensin II-infused mice.
  • Assessment of aortic structural changes (thickness, fibrosis, α-SMA staining).
  • Investigation of miPEP31's effect on PDGF-BB-induced VSMC proliferation and its nuclear localization.
  • Mechanistic studies involving Trps1 and miR-31 expression analysis.

Main Results:

  • miPEP31 administration mitigated Ang II-induced aortic thickening and fibrosis, while deficiency aggravated these changes.
  • miPEP31 inhibited PDGF-BB-induced VSMC proliferation and reduced Ang II-induced α-SMA staining.
  • miPEP31 localizes to the nucleus and acts as a transcriptional repressor, inhibiting miR-31 expression via cooperation with Trps1.
  • miPEP31 expression is endogenous in VSMCs.

Conclusions:

  • miPEP31 plays a protective role against Ang II-induced vascular remodeling by inhibiting VSMC proliferation.
  • miPEP31 functions as a transcriptional repressor, cooperating with Trps1 to suppress miR-31 expression.
  • These findings highlight miPEP31 as a potential therapeutic agent for hypertensive target organ damage.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
12.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K